Our Scientists Team
Kent Miller, Ph.D., M.D.
Dr. Miller is Professor Emeritus of Medicine and Microbiology at the University Of Miami School Of Medicine where he served as Chief of Laboratory Medicine and Director of clinical laboratories for the University of Miami Hospitals and Clinics. Previously, Dr. Miller served as the Assistant Director and Chief of Laboratory Medicine for the New York State Department of Health, and Associate Professor of Pathology at Albany Medical College.
Dr. Miller's research interests are primarily focused on clinical diagnostics and the clinical applications of natural toxins. He performed extensive work on bacterial toxins, especially tetanus toxin, and the development of tetanus toxoid for human use. While at the University of Miami, Dr. Miller collaborated with Dr. Maury Sanders to research the antiviral properties of snake a-toxins. Dr. Miller continued research on PVX (formerly known as PANAVIRA™) and to develop innovative clinical diagnostics. Furthermore, Dr. Miller has authored several papers in peer reviewed journals on this antiviral technology. He has one approved patent and another patent application in review for PVX.
Dr. Miller oversees the management and monitoring of current research processes, the development of the new bioengineered production process, support of the FDA approval process and support of all new patent applications.
Jay E. Yourist, Ph.D.
As a colleague in the Department of Microbiology at the University of Miami, Dr. Yourist worked with Dr. Miller, his Ph.D. advisor, to perform the initial basic research of this technology including its mechanism of action.
As the founder and CEO of CRP Network, LLC in Miami, Florida, he guided an organization that provided clinical research services for new biotechnologies, nutraceuticals and medical devices primarily in the specialty areas of cardiovascular disease, diabetes, infectious disease, rheumatology, wound care, and physical rehabilitation.
Also, Dr. Yourist served as an Assistant Professor of Medicine at the University Of Miami School Of Medicine, where he had both teaching and basic research responsibilities. His research included studies in virology, neurochemistry and enzymology focusing on processes mediated by phosphorylation.
Dr. Yourist has published several papers and has a patent application in current review regarding "Coordinated Healthcare and Disability Management Systems."
Dr. Yourist will serve as our Chief Executive Officer (See Our management Team) and in addition to his overall management responsibilities he will concentrate on the clinical trials, the FDA approval process, and the development of the new synthesis and bioengineered production processes.
Neil D. Ross, Pharm. D.
Dr. Neil D. Ross has had an extensive career in the pharmaceutical and nutraceutical industry beginning in 1975 with Lederle Labs where he developed and implemented the Centrum, Caltrate, Stresstab and Materna vitamin formulations and all line extensions. Later, at International Specialty Products he developed 5 new excipients for the industry including, Polyplasdone XL, Pharmasolve, Plasdone K90, etc. He also helped develop, with various companies, product technologies such as Transdermal, CR tablets, Quick dissolve tablets, etc.
To date, he has developed over 500 formulations covering vitamins, minerals, herbals, OTC's and nutraceuticals. He developed a complete validation processes for a new facility covering parts 211 and 111 of the CFR (FDA Chemical and Food Registry), process and cleaning validation as well as setting up a complete stability program for both nutra and pharma products. These are based on novel technology developed by Dr. Ross.
Dr. Ross graduated from the University of Missouri with degrees in Biological Research and Pharmacy. He has been on various USP (United States Pharmacopeia) committees for excipients and nutraceuticals and was a founding member of International Pharmaceutical Excipient Council and the American Association of Pharmaceutical Scientists organizations. He has given numerous presentations and lectures at: Pharm Tech (Tablet disintegrants); AAPS annual meeting (excipient registrations globally); Pharm Tech Mexico (new novel tablet technologies); CPhI China (new effervescent technologies); Pharm Technology Conference Indonesia (Formulation technologies of 2000).
Dr. Ross will serve Nuovo Biologics as Vice President for Product Operations. In this role he will assure that Nuovo Biologics meets all FDA site and process requirements. In addition, he will support Dr. Miller in the perfection of the new bioengineered production process and will coordinate with Drs. Austin and Yourist on the design and completion of the clinical trials.
Mr. Joseph Buettner, M.S.
Mr. Buettner, the Nuovo Biologics Peptide Chemistry Manager, has over 27 years' experience in the pharmaceutical industry with proven accomplishments in GMP/GLP bio-assays (development, qualification and validation as per ICH guidelines), quality control lab management, and project management (exploratory research, product development, manufacturing and pre-clinical for biologics). He has seven patents in biologics manufacturing for compounds and processes, and over 20 refereed journal articles and symposia oral presentations.
Mr. Buettner received his Masters of Science in Microbiology/Molecular Biology and Bachelors of Science in Zoology/Subcellular Biology from the University of Wyoming. He has formal Clinical Research training from Campbell University, formal project management and small group supervision training.
His recent scientific endeavors include consulting for biologics bioanalytics/QC and product development for both human and veterinary biologic therapeutics. He was the Principle Investigator for a government contract lab for forensic identification of all small molecule, heterocycle and protein toxins under an ISA/Secret clearance for the Department of Defense and the Intelligence Community. Mr. Buettner spent over 11 years at the Bayer Corporation Biologics Division providing support in Bioanalytics on product development teams and manufacturing trouble-shooting.
Mr. Buettner resides in South Florida with his wife where he actively enjoys scuba diving, fishing and boating in the warm waters of the Atlantic and Caribbean waters.
Dr. Lester Mandelker
Dr. Mandelker, who has been in private practice since 1972 is a graduate of Michigan State University for both his undergraduate and veterinary degrees. The Community Veterinary Hospital, in Largo Florida, is an AAHA Certified Hospital and Dr. Mandelker maintains active memberships in AVMA, FVMA, AAHA, FVMA, ABVP and the FAAVPT.
Over the last several decades Dr. Mandelker has maintained a high degree of peer respect and acknowledgement. From 1990 to 1992, he was the President/Secretary of the Pinellas County (Florida) Veterinary Medical Association. He was selected among the nation's top veterinarians 2006 & 2007 by the Consumer's Research Council of America and is a Member of the Executive Board of the Association for Pet Obesity Prevention. He was Chairman of Examination Committee of the American Board of Veterinary Practitioners from 1900 to 1992.
Since 1986, Dr. Mandelker has been a Diplomat of The American Board of Veterinary Practitioners and is certified in Canine and Feline Medicine. His Specialty Interest is Pharmacology, Nutraceuticals and Antioxidants. Dr. Mandelker is also a Fellow of the American Academy of Pharmacology and Therapeutics (FAAVPT).
Dr. Mandelker has published over 175 scientific articles on pharmacology, medicine and nutraceuticals in journals such as: AVMA journal, VM/SAC, Veterinary Forum and The Veterinary Clinics of North America.
Dr. Mandelker and done extensive work in pharmacology and first introduced various human pharmacological agents to the veterinary medicine such as Tramadol analgesic for pain in dogs and cats, Niacin for hyperlipidemia in dogs, Amitryptyline for use in boarding dogs and Accolate for use in feline sinusitis and canine respiratory diseases as well as many other first. He continues his active interest in animal pharmacology as a Pharmacology Consultant for Veterinary Forum, the Veterinary Information Network and is in demand as a speaker on Veterinary Pharmacology.